Nadra Belamri Saal is an experienced medical professional with a focus on oncology. Nadra currently holds the position of Medical Director at Fosun Pharma USA Inc. since June 2023. Prior to that, they worked as a Medical Director at MSD from January 2019. In this role, they were responsible for medical pre-launch and launch excellence of various cancer treatments. Nadra also collaborated closely with clin dev for site selection and study accrual management, and participated in market-access dossiers. Before MSD, Nadra worked as a Medical Manager Oncology at Roche from May 2014 to January 2019. Nadra was involved in content generation for internal and external stakeholders, training materials for field teams, and medical education for healthcare professionals. Nadra also had strong collaborations with cooperative groups for patient data collection and participated in international medical plan preparations. Prior to Roche, they worked as a Clinical Research Associate Trainee at Departement de l'information medicale CHU Montpellier in 2013 and at Service des maladies vasculaires CHU Montpellier in 2012.
Nadra Belamri Saal's education history begins in 2003, when they enrolled at the Université de médecine d'Alger. Nadra pursued a Doctorat en médecine in the field of Médecine générale, completing their studies in 2011. Following this, from 2011 to 2013, they attended UFR Médecine Montpellier, where they earned a Master 2 degree in Conception, gestion et évaluation des essais thérapeutiques.
June, 2023 - present